Searching journal content for articles similar to Liu et al. 20 (4): 603.

Displaying results 1-4 of 4
For checked items
  1. Review:
    • Rengyun Liu and
    • Mingzhao Xing
    TERT promoter mutations in thyroid cancer Endocr Relat Cancer 23 (3) R143-R155, doi:10.1530/ERC-15-0533 first published on 5 January 2016
    ...sinology, Diabetes and Metabolism, Correspondence to M Xing Key Words " TERT promoter mutation " thyroid cancer " telomerase reverse transcriptase " BRAF V600E mutation " genetic molecular markers " prognosis " diagnosis Telomerase reverse transcriptase (TERT) is the catalytic Telomerase is well...
  2. Research:
    • Ebtesam Qasem,
    • Avaniyapuram Kannan Murugan,
    • Hindi Al-Hindi,
    • Mingzhao Xing,
    • Mai Almohanna,
    • Meshael Alswailem,
    • and Ali S Alzahrani
    TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population Endocr Relat Cancer 22 (6) 901-908, doi:10.1530/ERC-15-0396 first published on 9 September 2015
    ...) Abstract Telomerase reverse transcriptase (TERT) promoter mutations C228T and C250T have recently been described in follicular cell-derived thyroid cancer (TC) in patients from North America and Europe. In this study, we explored whether these findings could be replicated in patients from a different...
  3. Review:
    • Vincenzo Marotta,
    • Concetta Sciammarella,
    • Annamaria Colao,
    • and Antongiulio Faggiano
    Application of molecular biology of differentiated thyroid cancer for clinical prognostication Endocr Relat Cancer 23 (11) R499-R515, doi:10.1530/ERC-16-0372 first published on 30 August 2016
    ...of thyroid cancer, and their possible clinical application is currently under evaluation. Particularly, mutations involving the promoter of the telomerase catalytic subunit telomerase reverse transcriptase (TERT) and the tumour suppressor TP53 are emerging as feasible tools for molecular prognostication...
  4. Thematic Review:
    • Susan J Hsiao and
    • Yuri E Nikiforov
    Molecular approaches to thyroid cancer diagnosis Endocr Relat Cancer 21 (5) T301-T313, doi:10.1530/ERC-14-0166 first published on 14 May 2014
    .... 2014).best studied is the BRAF V600E mutation. The presence of Published by Bioscientifica Ltd. the BRAF V600E mutation in papillary thyroid cancer was found to be associated with poor prognostic factors such as extrathyroidal invasion, lymph node metastases, and recurrence (reviewed in Xing (2007...
For checked items

Search Results

New Search

Modify Results

Citation format:
Results / page:
Results order:

This search

  • Alert me when new articles matching this search are published
  • Download all citations on this page to my citation manager

New Articles: issue in progress

  1. November 2017, 24 (11)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most